5 articles tagged with "Biotech"
In a significant move to enhance its oncology pipeline, Gilead has announced the acquisition of Tubulis, a German biotech firm, for more than $3 billion.
Strategic angle: Insights from Alex Zhavoronkov on becoming a productive biotech AI company.
Strategic angle: The drug demonstrates improved skin clearance, marking a significant advancement in lupus treatment.
Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden.
This approval follows previous claims of its potential use in treating autism symptoms.